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The relationship between the rate of glutathione disulfide (GSSG) export and the energy state was studied 
in isolated perfused rat heart. The intracellular GSSG level was maintained at saturation for transport (7.5 
nmol GSSG . min -1 . g heart -1) by continuous perfusion with 20 PM t-butyl hydroperoxide. GSSG release 
was substantially restricted upon the addition of inhibitors of mitochondrial respiration such as KCN, anti- 
mycin A or rotenone. In contrast, no effect was observed on GSSG release during potassium-induced cardi- 
ac arrest, although changes in oxygen consumption and coronary flow were similar to those observed with 
KCN. The dependence of the GSSG transport rate on the cytosolic free ATP/ADP ratio reveals that GSSG 
transport is half-maximal at (ATP/ADP) rree x 10. The capacity of GSSG transport was unchanged by infu- 
sion of epinephrine, norepinephrine or dibutyryl cyclic AMP. 
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1. INTRODUCTION 
Glutathione disulfide (GSSG) and glutathione 9 
conjugates, generated from glutathione peroxidase 
and glutathione transferase reactions, are 
eliminated from cardiac cells [ 1,2]. The elimina- 
tion is an important step in detoxication as well as 
in interorgan glutathione turnover and processing 
to mercapturic acids in the kidney. Work with 
isolated perfused heart showed the existence of a 
common transport system for GSSG and 
glutathione Sconjugates, and an activation energy 
of 12 kcal-mol-’ was estimated for GSSG 
transport [ 11. 
This study addresses the question of dependence 
of cardiac GSSG transport on the cytosolic free 
ATP/ADP ratio, (ATP/ADP&. The investiga- 
tion of GSSG transport in isolated perfused heart 
has several advantages as compared to other 
organs, for example: (i) saturation in the rate of 
GSSG release with respect to the intracellular 
GSSG level can be achieved and maintained over a 
sufficient experimental period; (ii) the energy state 
can be changed by the inhibition of mitochondrial 
respiration to decrease (ATP/ADP)f,, or by a 
potassium-induced cardiac arrest to increase 
(ATP/ADP)frcc; (iii) the level of (ATP/ADP)free 
can be assessed by creatine phosphate/creatine; 
(iv) the intracellular pH as well as creatine 
phosphate and ATP levels are readily monitored 
with “P-NMR methods. 
Here we present evidence that the cardiac 
transport of GSSG is an active transport, and show 
that the rate of transport is a function of cytosolic 
(ATP/ADP)f,,, . 
2. MATERIALS AND METHODS 
2.1. Biochemicals and enzymes 
NADPH, NADH, ATP, glycerate 3-phosphate, 
phosphoenolpyruvate, dibutyryl cyclic AMP, 
pyruvate kinase, myokinase and 3_phosphoglycer- 
ate kinase/glyceraldehyde-3-phosphate d hydro- 
genase (Boehringer, Mannheim), antimycin A, 
rotenone, epinephrine, norepinephrine and cre- 
atine kinase (Sigma), N-ethylmaleimide (Merck) 
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and quaternary aminoethyl (QAE)-Sephadex A-25 
(Pharmacia) were obtained from the commercial 
sources indicated. All other chemicals were of 
analytical grade. 
2.2. Perfusion of rat heart 
Hearts of male Wistar rats of 190-220 g body 
wt, fed on stock diet (Altromin), were perfused as 
described [l], and the performance of cardiac 
functions was monitored according to [1,2]. The 
oxygen concentration in effluent perfusate was 
measured with a Clark-type oxygen electrode. For 
measurement, a Tygon tube with a diameter of 
1 mm was inserted into the pulmonary artery and 
a portion of the effluent perfusate was pumped 
through the electrode chamber at a constant rate of 
0.8 ml/min. 
2.3. Assay of metaboh’tes in heart 
The perfused hearts were freeze-stopped using 
aluminium tongs cooled with liquid Nz, and were 
pulverized in a percussion mortar at liquid NZ 
temperature. 200-250 mg of powder was suc- 
cessively homogenized in 1.2 ml of 1 M perchloric 
acid containing 2 mM EDTA (for the assay of 
adenine nucleotides, creatine and creatine 
phosphate) or in 1.2 ml of 1 M perchloric acid 
containing 2 mM EDTA and 50 mM N- 
ethylmaleimide (for GSSG assay). GSSG was 
measured according to [l]. ATP, ADP, AMP, 
creatine and creatine phosphate were determined 
by conventional enzymatic analyses [3,4]. 
2.4. Assay of GSSG in effluent perfusate 
This was carried out as described [l]. 
2.5. Measurement of intracellular pH with 
“P-NM? 
“P-NMR spectra of isolated perfused hearts 
were recorded with a Bruker WH 360 NMR spec- 
trometer operated in the Fourier transform mode. 
The heart was placed in a 15-mm NMR sample 
tube and inserted into a probe which was seated in 
the bore of a superconducting magnet (8.5 T). 
Spectra were taken by 80 scans of a 60” broadband 
pulse with a 0.6 s interpulse delay. The in- 
tracellular pH was determined from the chemical 
shift of inorganic phosphate signal as described in 
WI. 
3. RESULTS AND DISCUSSION 
3.1. Effect of inhibition of mitochondrial 
respiration on GSSG release 
When the heart was perfused with 20 pM t-butyl 
hydroperoxide, the level of intracellular GSSG was 
increased, and GSSG release from the heart 
reached a maximal rate of 7.5 nmol~min-‘.g 
heart-’ [l]. The rate of GSSG release remained 
constant during the perfusion, and no remarkable 
change was observed in cardiac functions such as 
heart beat rate, left ventricular pressure, coronary 
flow and oxygen consumption rate. This enabled 
us to assess the capacity of cardiac GSSG transport 
under various perfusion conditions by referring to 
the maximal rate of GSSG release. 
Fig.1 shows the effect of the inhibition of 
mitochondrial respiration with KCN on the max- 
imal rate of GSSG release. When KCN was infused 
at a concentration of 0.5 mM during the perfusion 
with t-butyl hydroperoxide, the oxygen consump- 
tion of the heart dropped from 5.1 to 
1.2 pmol - min-’ . g heart-‘, and a remarkable 
decrease was observed in the rate of GSSG release, 
in spite of the increase of coronary flow rate. As 
shown in fig. 1, changes were reversible. After ter- 
mination of the KCN infusion the decreased GSSG 
release recovered to the initial rate. A similar 
change in GSSG release was observed with an 
anoxic perfusion. When antimycin A or rotenone 
was infused at 5 FM, a more remarkable decrease 
was seen in the GSSG release rate; however, the ef- 
fect was irreversible (not shown). 
3.2. Effects of cardiac arrest and cardiac 
stimulation on GSSG release 
Fig.2 shows the effect of potassium-induced car- 
diac arrest on the rate of GSSG release. KC1 was 
infused at 20 mM during perfusion with t-butyl 
hydroperoxide. Thereby, the heart beat was com- 
pletely arrested, due to the depolarization of the 
resting membrane potential of the cardiac cells. 
Changes in the coronary flow and the oxygen con- 
sumption were very similar to those observed upon 
the addition of KCN (fig.lA). However, in- 
terestingly, the maximal rate of GSSG release was 
little affected. This result, therefore, presents a 
control for the effect of KCN on GSSG release rate 
shown in fig.1. 
Likewise, the cardiac function was stimulated by 
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Fig.1. Effects of the inhibition of mitocbondrial 
respiration by KCN on cardiac functions and on GSSG 
release. The heart was perfused with 204 t-butyf 
hydroperoxide for 25 min, and during the perfusion 
KCN was infused at 0.5 mM for 5 min. (A) Time 
courses of left ventricular pressure, oxygen 
concentration in effluent perfusate and of coronary flow 
rate. (B) GSSC release shown as mean + SE of 3 
different experiments. 
the addition of epinephrine (50 i&f), 
norepinephrine (50 nM) and dibutyryl cyclic AMP 
(SO,UM), and the maximal rate of GSSG release 
was not significantly affected (not shown), The 
results indicate that the GSSG release is a process 
inde~nde~t of the membrane potential and of the 
hormonal regulation related with adrenergic 
hormones. 
3.3. GSSG transport and cwdiac energy state 
Table 1 summarizes data on GSSG release rate, 
r 
20 30 40 60 
Psrf"s,onTlme (mln) 
F&,2. Effect of potassium-induced cardiac arrest on 
GSSG release. The heart was perfused with 20/cM t- 
butyl hydroperoxide for 25 min, and during the 
perfusion KC1 was infused at a concentration of 20 mM 
for 5 mm. (A) Time courses of left ventricular pressure, 
oxygen concentration in effluent perfusate and of 
coronary flow rate. (B) GSSG release shown as mean f 
SE of 3 different experiments. 
intracellular GSSG, ATP, ADP, AMP, creatine 
phosphate (CrP) and creatine (Cr) in hearts per- 
fused under various conditions. Perfusion with 
20&M t-butyl hydroperoxide enhanced the in- 
tracellufar GSSG Ieve by 150 nmol r g heart-’ 
without any remarkable change in the energy 
parameters, as compared with the control. The ad- 
dition of 20 mM KC1 to induce cardiac arrest dur- 
ing perfusion with t-butyl hydroperoxide increased 
the ratio of creatine phosphate to creatine, whereas 
no significant change was observed in the GSSG 
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Table 1 
Effects of KCI, KCN and antimycin A on GSSG release and on metabolites in the heart perfused with t-butyl 
hydroperoxide 
GSSG Intracellu- cmol . g heart-’ 
release lar GSSG 
(nmol - min-’ (nmol f g ATP ADP AMP CrP Cr 
+g heart-‘) heart-‘) 
Control 0.10 f 0.01 15 f. 1 3.72 f 0.12 0.66 f 0.01 0.13 Z!Z 0.03 4.88 f 0.13 4.26 f 0.09 
t-Butyl hydroperoxide 
(20 FM) 7.5 i 0.3 161 + 27 3.74 & 0.10 0.65 f 0.02 0.17 i 0.01 4.49 + 0.28 4.16 f 0.27 
+ KC1 (20 mM) 7.6 -+ 0.2 170 f 6 3.65 + 0.08 0.66 f 0.01 0.17 f 0.01 5.40 + 0.27 3.55 f 0.09 
+ KCN (0.5 mM) 4.3 f 0.5 252 f 18 1.98 + 0.12 0.93 i 0.05 0.51 ~fi 0.07 0.50 + 0.09 6.86 + 0.30 
+ antimycin A (5rM) 2.9 + 0.2 283 f 10 1.39 f 0.10 1.06 f 0.05 1.33 f 0.18 0.28 f 0.02 7.27 f 0.06 
In the control experiment, hearts were perfused under standard perfusion conditions for 40 min and freeze-stopped. 
In the other experiments, hearts were perfused with 20 FM t-butyl hydroperoxide from 25 min perfusion time, and KCl, 
KCN or antimycin A was infused from 35 min as shown in figs 1 and 2. The perfusion was terminated by freeze-stop 
at 40 min. GSSG release rate was observed at 39-40 min perfusion time. Meta~lites in the heart were assayed as 
described in section 2. Data are shown as means f SE (n = 4) 
release and intracellular GSSG level. It is notewor- 
thy that the intracellular GSSG level was increased 
in hearts which were perfused with KCN or an- 
timycin A, while the rate of GSSG release dropped 
strikingly (f&l, table 1). Thus, the decline of the 
GSSG release rate shown in fig.1 is not ascribable 
to a decrease in intracellular GSSG level. In those 
hearts, ATP content was about half the control 
level and creatine phosphate content was con- 
spicuously low (table 1). 
In heart, adenine nucleotides are found in both 
mitochondrial and extramitochondrial spaces [7]. 
A substantial fraction of cytosolic ADP and a part 
of ATP are bound to contractile proteins [8]. 
Therefore, assuming near-equilibrium of the 
creatine kinase reaction, the cytosolic free 
ATP/ADP ratio, (ATP/ADP&, was estimated 
as a suitable parameter for the evaluation of the 
cytosolic energy state. Fig.3 shows the relationship 
between GSSG transport rate and the estimated 
(ATP/ADP)r~~~. Heart perfused under standard 
perfusion condition gave an (ATP/ADP)f,,, of 
180 + 11 (n = 4), and 171 f 10 (n = 4) was seen 
for heart perfused with 20 PM t-butyl hydroperox- 
ide for 15 min. Potassium-induced cardiac arrest 
enhanced the ratio up to 253 f 13 (n = 4). When 
mitochondrial respiration in heart was inhibited 
with KCN or antimycin A, the (ATP/ADP)r,,, 
level dropped maximally by one order of 
magnitude. In this case, the GSSG transport was 
found to be closely linked with the lowered level of 
(ATP/ADP)r,,. Under the corresponding condi- 
tions, intracellular pH assessed with “P-NMR 
shifted just from 7.05 to 6.80. Thus, the result 
shown in fig.3 suggests the direct dependence of 
the capacity of cardiac GSSG transport on the 
cytosolic energy state. 
3.4. Concluding remarks 
Although the phenomenon of GSSG release was 
observed in different organs and cell types [lo], the 
detailed mechanism has not been fully understood. 
Only in erythrocytes, the ATP dependence of the 
GSSG release was proven by using inside-out mem- 
brane vesicles [l I]. Recently, it has been reported 
that a plasma membrane preparation from rat 
hepatocytes contained ATPase activity which was 
activated by GSSG 1121, and the implication of the 
ATPase activity with hepatic transport of GSSG is 
suggested. The present study demonstrates a close 
relationship between the rate of GSSG release and 
cytosolic free ATP/ADP ratio, proving the ex- 
istence of an energy-dependent GSSG transport 
system in heart. This is the first report which 
demonstrates this in an intact perfused organ. 
As exemplified by a competition between GSSG 
and glutathione S-conjugate releases, cardiac 
GSSG transport system is considered to take a role 
131 
Volume 200, number 1 FEBSLETTERS May 1986 
100 
011 
10 30 100 300 
(ATP/ADP)fr,, 
Fig.3. Relationship between rate of GSSG transport and 
(ATP/ADP)r,,. Hearts were perfused with 20pM t- 
butyl hydroperoxide and with KC1 (20 mM), KCN (SO, 
100 or 5OOrM) or antimycin A (5 PM) in the same 
manner as shown in figs 1 and 2, and were freeze- 
stopped at 40 min perfusion time. GSSG transport rate 
is shown as the ratio of the GSSG release rate at 
39-40 min to the release rate at 34-35 min; 100% 
corresponds to 7.5 f 0.2 nmol.min-‘.g heart-’ (n = 
20). (ATP/ADP)r,, was estimated from the contents of 
creatine and creatine phosphate in the freeze-stopped 
heart, assuming near-equilibrium of creatine kinase 
reaction. The equilibrium constant of the reaction was: 
KCK = 
[ATPI lCr1 
[ADP][CrP][H+] 
= 1.66 x IO9 M-’ (91. 
[H+] was determined in a separate series of experiments 
with “P-NMR. pH = 7.05 for data of (ATP/ADP)f,, 2 
80, pH = 6.80 for (ATP/ADP)f,, < 80. 
in the elimination of glutathione S-conjugates 
which have been generated from glutathione 
transferase reaction ([1,2]; see [13] and [14] for rat 
cardiac glutathione transferases). However, the 
energy dependence of glutathione S-conjugate 
transport is more difficult to study because the 
maximal rate of glutathione S-conjugate release 
cannot be maintained for a sufficient time. 
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